New Data Shows How Plasma Detect Assay May Support Cancer Treatment Decisions
Research demonstrates the MRD assay’s utility in tracking disease progression and predicting treatment outcomes.
Read More
Search Results for: lung cancer
Lunit, Labcorp Partner on AI-Powered Digital Pathology Research
The collaboration combines Labcorp’s clinical expertise with Lunit’s AI algorithms to analyze tumor microenvironments and enhance biomarker discovery.
Read MoreAI Diagnostic Applications Showcased at AMP 2025 Annual Meeting
Studies demonstrate artificial intelligence achieving 93% cancer diagnostic accuracy and enabling noninvasive tumor analysis through spinal fluid testing.
Read More
Multi-Cancer Blood Test Could Significantly Reduce Late-Stage Diagnoses
A simulation model shows that annual liquid biopsy screening would increase early-stage cancer detection by up to 30% while cutting stage IV diagnoses by 45%.
Read More
Breath Test Technology Shows Promise for Early Lung Cancer Detection
University of Texas at Dallas researchers combine electrochemical biosensors with AI to identify volatile organic compounds linked to thoracic cancers.
Read More